Constance Therapeutics, Inc. — Form D
Constance Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-05. The offering totals $4.2M, of which $4.2M was reported sold. Industry: Other.
Offering
- Filed: 2018-03-05
- Form: D
- Accession: 0001646331-18-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $4.2M
- Amount sold: $4.2M
- Remaining: $34
- Minimum investment: $25K
- Investors: 9
- Date of first sale: 2018-02-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-306932
Issuer
- Name: Constance Therapeutics, Inc.
- CIK: 0001646331
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 681 HOWARD STREET, SAN FRANCISCO, CA, 94103
- Phone: 510-455-1473
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Constance Finley | Director | San Francisco, CA |
| Constance Finley | Executive Officer | San Francisco, CA |
| Constance Finley | Promoter | San Francisco, CA |
Other filings by this issuer (2)
More